GlassScriptPhysician profile
Emily Link
NPI 1881038578
$1,327.68
in general payments reported to CMS, 2019-2025
17 companies · $756 in 2025
The $756 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.13 · 2023: $300 · 2024: $260 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,176 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,176.05 |
| Education | $139.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $323.00 | 2025 | Rapiblyk |
| Medtronic, INC. | $264.58 | 2024-2025 | Mycarelink, Aurora Ev-Icd Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.00 | 2023-2025 | Jardiance |
| Heartflow, INC. | $144.25 | 2023-2025 | Ffrct |
| Pfizer INC. | $118.40 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.92 | 2025 | |
| Amgen INC. | $46.32 | 2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $29.57 | 2024 | |
| Philips North America LLC | $22.56 | 2025 | Mcot |
| Altathera Pharmaceuticals LLC | $22.17 | 2025 | Sotalol Hydrochloride |
| Novartis Pharmaceuticals Corporation | $19.62 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $19.25 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $16.07 | 2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $15.94 | 2025 | Farxiga |
| Lilly USA, LLC | $14.86 | 2025 | Mounjaro, Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.04 | 2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Link listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.